|
Bupikomid
| Bupikomid
|
![]()
|
| IUPAC ime
|
| |
|---|
| 5-Butil-2-piridinkarboksamid |
|
| Drugi nazivi
|
Sch-10595; Fusaramide[1]
|
| Identifikacija
|
| CAS registarski broj
|
22632-06-0  Y
|
| PubChem[2][3]
|
31447
|
| ChemSpider[4]
|
29167
|
| UNII
|
0X3H76N0HY
|
| Jmol-3D slike
|
Slika 1
|
|
|
|
|---|
InChI=1S/C10H14N2O/c1-2-3-4-8-5-6-9(10(11)13)12-7-8/h5-7H,2-4H2,1H3,(H2,11,13) Y
Kod: VKSPIPWLHGKJQO-UHFFFAOYSA-N Y
InChI=1/C10H14N2O/c1-2-3-4-8-5-6-9(10(11)13)12-7-8/h5-7H,2-4H2,1H3,(H2,11,13)
Kod: VKSPIPWLHGKJQO-UHFFFAOYAT |
|
| Svojstva
|
| Molekulska formula
|
C10H14N2O
|
| Molarna masa
|
178.23 g mol−1
|
|
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
|
| Infobox references
|
Bupikomid je hemijsko jedinjenje koje je razvilo i proizvodi preduzeće Lanospharma Laboratories Company, Ltd. Ono se eksperimentalno koristi kao beta blokator i kao jak vazodilatator. Nuspojave bupikomida su redukovani sistolni, dijastolni i srednji arterijski pritisak.[5][6]
Reference
- ↑ Bupicomide, Chemical Book
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED (1976). „Systemic and renal hemodynamic effects of bupicomide: A new vasodilator”. American heart journal 92 (3): 335–9. PMID 782220.
- ↑ Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL (1975). „Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine”. Clinical pharmacology and therapeutics 18 (2): 145–53. PMID 1097150.
Vanjske veze
|
|
